
    
      As we know, recurrence and metastasis could happen in hepatocellular carcinoma even after
      radical resection.One reason is that virus hepatitis B could be one factor contributing to
      the carcinogenesis of hepatocellular carcinoma.To investigated whether anti-viral therapy
      could improve the efficacy of radical resection of hepatitis B virus (HBV)-related
      hepatocellular carcinoma(HCC),we planed to conduct this clinical trial.
    
  